Greater effects of fluoxetine and its combination with (-)-Pindolol in elevating hypothalamic serotonin in rats during dark hours

Chinese Journal of Physiology

Volumn 40, Issue 2, 1997, Pages 57-61

  Dreshfield, Laura J ^a   Rocco, Vincent P ^a   Wong, David T ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT reuptake inhibitor; 5 HT 1A antagonist; Behavioral activity; Microdialysis

Indexed keywords

FLUOXETINE; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOTHALAMUS; LIGHT DARK CYCLE; MALE; NONHUMAN; RAT; SEROTONIN RELEASE; SEROTONIN UPTAKE;

EID: 0030806870     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol. 352: 157-165, 1995.
2. 1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol. 353: 630-640, 1996.
3. Auerbach, S. B., Minzenberg, M. J., and Wilkinson, L. O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499: 281-290, 1989.
4. 1A autoreceptors, in conscious rats. Society for Neurosci. Abst. 21: 859, 1995.
5. 1A receptors. Neurochem. Res. 21: 557-562, 1996.
6. Engleman, E.A., Perry, K.W., Mayle, D.A. and Wong, D.T. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine reuptake inhibitor. Neuropsychopharmacol. 12: 287-295, 1995.
7. 1A agonist and antagonist drug administration in behaving cats. J. Pharmacol. Exp. Ther. 270: 1345-1358, 1994.
8. Fomal, C. A., Metzler, C. W., Gallegos, R. A., Veasey, S. C., McCreary, A. C., and Jacobs, B. L. WAY-100635, a potent and selective 5-hydroxytryptamine 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther., 278: 752-762, 1996.
9. 1A autoreceptor antagonists restore serotonergic neuronal activity after acute fluoxetine treatment in behaving cats. Society for Neurosci. Abst. 21: 977, 1995.
10. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115: 1064-1070, 1995.
11. Hajos, M., Gartside, S. E., and Sharp, T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol. 351: 624-629, 1995.
12. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: amicrodialysis study. J. Neurochem. 60: 776-779, 1993.
13. Invernizzi, R., Belli, S., and Samanin, R. Citalopram's ability to increase extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584: 322-324, 1992.
14. Jacobs, B.L., Fornal, C.A., and Wilkinson, O. Neurophysiological and neurochemical studies of brain serotonergic neurons in behaving animals. Ann. NY Acad. Sci. 600: 260-268, 1990.
15. Malagie, I., Jacquot, C., and Gardier, A. M. Effects of acute paroxetine and fluoxetine on extracellular serotonin in the raphe: an in vivo microdialysis study. Society for Neurosci. Abst. 21: 866, 1995.
16. McMahon, L., Thiagarajan, R., Green, T., and Wellman, P.J. Diurnal rhythms of extracellular serotonin within rat hypothalamic paraventricular nucleus. Society for Neurosci. Abst. 21: 1459. 1995.
17. Meeusen, R., Thorre, K., Sarre, S., De Meirleir, K., Ebinger, G., and Michotte, Y. The effect of exercise and L-tryptophan administration on extracellular serotonin metabolism in rat hypothalamus. Society for Neurosci. Abst. 21: 1691, 1995.
18. Paxinos, G. and Watson, C. The rat brain in stereotaxic coordinates. London, England: Academic Press, 1986.
19. Perry, K.W. and Fuller, R.W. A method for the simultaneous assay of norepinephrine, dopamine and serotonin and their metabolites in the rat hypothalamic microdialysates. Society for Neurosci. Abst., 19: 1174, 1993.
20. Perry, K. W. and Fuller, R. W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50: 1683-1690, 1992.
21. Rueter, L. E. and Jacobs, B. L. Changes in forebrain serotonin at the light-dark transition: correlation with behaviour. NeuroReport 7: 1107-1111, 1996.
22. 1B receptor subtype ligands. Society for Neurosci. Abst. 11: 47, 1985.
23. Trulson, M.E., and Jacobs, B. L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 163: 135-150, 1979.
24. Wong, D. T., Bymaster, F. P., and Engleman, E. A. Presynaptic regulation of extracellular serotonin concentrations in brain. In: Serotonin in the Central Nervous System and Periphery, edited by A. Takada and G. Curzon. Amsterdam, The Netherlands: Elsevier Science B. V, 1995, pp. 3-13.
25. Wong, D.T., Bymaster, F.P. and Engleman, E.A. Prozac (Fluoxetine, Lilly 110140), the first selective serotonin reuptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57: 411-441, 1995.